Abstract
Objective
UTUCC is a rare tumor, and most reports on prognostic factors come from small single-center series. The objective of this article was to provide an updated overview of current clinical, pathological and biological prognostic factors of UTUC.
Methods
PubMed was searched for records from 2002 to 2010 using the terms “prognostic factors”, “recurrence”, “survival”, and “upper tract urothelial carcinoma”. Among identified citations, papers were selected based on their clinical relevance.
Results
Classical clinical factors that influence UTUC prognosis include age, presence of symptoms, hydronephrosis, and interval from diagnosis. Many biomarkers have shown promises to better appraise the natural course of UTUC although none is currently used in clinical practice. Stage, grade, lymph node metastases, lymphovascular invasion, tumor necrosis, and tumor architecture are strong pathological parameters. RNU is the standard treatment of localized UTUC. Both laparoscopic and open approaches seem to offer similar cancer control. Lymph node dissection increases staging accuracy and might confer a survival benefit.
Conclusion
RNU is the standard treatment for most patients with UTUC. Recent multicenter studies confirmed the prognostic value of classical prognostic parameters. Better survival prediction might be obtained with prognostic systems including clinical data and new biomarkers.
Similar content being viewed by others
Abbreviations
- CIS:
-
Carcinoma in situ
- CSM:
-
Cancer-specific mortality
- LN:
-
Lymph node
- LVI:
-
Lymphovascular invasion
- RNU:
-
Radical nephroureterectomy
- SEER:
-
Surveillance epidemiology and end results
- TNM:
-
Tumor, nodes, and metastases
- UTUC:
-
Upper tract urothelial carcinoma
- UTUCC:
-
Upper tract urothelial carcinoma collaboration
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
Oosterlinck W, Solsona E, van der Meijden AP et al (2004) EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46:147–154
Roupret M, Wallerand H, Traxer O et al (2010) Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology. Prog Urol 20:260–271
Zigeuner R, Pummer K (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53:720–731
Raman JD, Scherr DS (2007) Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol 4:432–443
Cornu JN, Roupret M, Carpentier X et al (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28:151–156
Bagley DH, Grasso M 3rd (2010) Ureteroscopic laser treatment of upper urinary tract neoplasms. World J Urol 28:143–149
Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 15(115):1224–1233
Shariat S, Godoy G, Lotan Y et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105:1672–1677
Jeldres C, Sun M, Lughezzani G et al (2010) Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer 116:3774–3784
Lughezzani G, Sun M, Perrotte P et al (2010) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology 75:321–327
Shariat SF, Favaretto RL, Gupta A et al (2010) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. doi:10.1007/s00345-010-0594-7
Patard JJ, Leray E, Cindolo L et al (2004) Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 172:858–862
Raman JD, Shariat SF, Karakiewicz PI et al (2010) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol (in press)
Inman BA, Tran VT, Fradet Y, Lacombe L (2009) Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer 1(115):2853–2862
Brien JC, Shariat SF, Herman MP et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69–73
Cho KS, Hong SJ, Cho NH, Choi YD (2007) Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology. 70:662–666
Ng CK, Shariat SF, Lucas SM et al (2011) Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol 29:27–32
Gore J, Lai J, Setodji C, Litwin M, Saigal C (2009) Project UDiA. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 115:988–996
Waldert M, Karakiewicz PI, Raman JD et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105:812–817
Fromont G, Roupret M, Amira N et al (2005) Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 48:764–770
Eltz S, Comperat E, Cussenot O, Roupret M (2008) Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 102:532–535
Roupret M, Azzouzi AR, Cussenot O (2005) Microsatellite instability and transitional cell carcinoma of the upper urinary tract. BJU Int 96:489–492
Matsui Y, Utsunomiya N, Ichioka K et al (2005) Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65:279–283
Huang WW, Huang HY, Liao AC et al (2009) Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection. Pathol Int 59:642–649
Hattori R, Yoshino Y, Komatsu T, Matsukawa Y, Ono Y, Gotoh M (2009) Pure laparoscopic complete excision of distal ureter with a bladder cuff for upper tract urothelial carcinoma. World J Urol 27:253–258
Capitanio U, Shariat SF, Isbarn H et al (2009) Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56:1–9
Favaretto R, Shariat S, Chade D et al (2010) Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 58(5):645–651
Roupret M, Smyth G, Irani J et al (2009) Oncological risk of laparoscopic surgery in urothelial carcinomas. World J Urol 27:81–88
Simone G, Papalia R, Guaglianone S et al (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56:520–526
Liapis D, de la Taille A, Ploussard G et al (2008) Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years. World J Urol 26:523–530
Hemal AK, Kumar A, Gupta NP, Seth A (2008) Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up. World J Urol 26:381–386
Thalmann GN, Markwalder R, Walter B, Studer UE (2002) Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 168:1381–1385
Nonomura N, Ono Y, Nozawa M et al (2000) Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol 38:701–704 (discussion 5)
Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H (2006) Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 176:48–52
Novara G, De Marco V, Gottardo F et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110:1715–1722
Raman JD, Ng CK, Scherr DS et al (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 57:1072–1079
Isbarn H, Jeldres C, Shariat SF et al (2009) Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol 182:2177–2181
Remzi M, Haitel A, Margulis V et al (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103:307–311
Margulis V, Youssef RF, Karakiewicz PI et al (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184:453–458
Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R (2006) Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 448:604–611
Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH (2009) The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 182:451–458 (discussion 8)
Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ (2010) Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology 75:328–332
Li CC, Chang TH, Wu WJ et al (2008) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54:1127–1134
Novara G, De Marco V, Gottardo F et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110:1715–1722
Huben RP, Mounzer AM, Murphy GP (1988) Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62:2016–2020
Roscigno M, Shariat SF, Margulis V et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181:2482–2489
Capitanio U, Suardi N, Shariat SF et al (2009) Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int 103:1359–1362
Roscigno M, Shariat SF, Freschi M et al (2009) Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology 74:1070–1074
Roscigno M, Shariat SF, Margulis V et al (2009) The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56:512–518
Bolenz C, Shariat SF, Fernandez MI et al (2009) Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int 103:302–306
Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H (2005) Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Urology 65:692–696
Shariat SF, Svatek RS, Tilki D et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105:1402–1412
Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K (2007) Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 178:2291–2296 (discussion 6)
Bolenz C, Fernandez MI, Trojan L et al (2009) Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int 103:1040–1046
Novara G, Matsumoto K, Kassouf W et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57:1064–1071
Kikuchi E, Margulis V, Karakiewicz PI et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 1(27):612–618
Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R (2004) Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 45:257–266
van der Poel HG, Antonini N, van Tinteren H, Horenblas S (2005) Upper urinary tract cancer: location is correlated with prognosis. Eur Urol 48:438–444
Langner C, Hutterer G, Chromecki T, Leibl S, Rehak P, Zigeuner R (2006) Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. J Urol 176:910–913 (discussion 3–4)
Simone G, Papalia R, Loreto A, Leonardo C, Sentinelli S, Gallucci M (2009) Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int 103:1052–1057
Zigeuner R, Shariat S, Margulis V et al (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57:575–581
Seitz C, Gupta A, Shariat S et al (2010) Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol 184:1895–1900
Shariat SF, Palapattu GS, Karakiewicz PI et al (2007) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 51:152–160
Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Piza P (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106:1319–1323
Wheat JC, Weizer AZ, Wolf JS Jr et al (2010) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol (in press)
Karam JA, Margulis V, Montorsi F et al (2008) Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy–results from a multicenter study. Eur Urol 54:961–963
Otto W, Shariat SF, Fritsche HM, et al (2011) Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol. doi:10.1007/s00345-011-0645-8
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
G. Verhoest and S. F. Shariat contributed equally to this work.
Rights and permissions
About this article
Cite this article
Verhoest, G., Shariat, S.F., Chromecki, T.F. et al. Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol 29, 495–501 (2011). https://doi.org/10.1007/s00345-011-0710-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-011-0710-3